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The cDNA encoding the precursor form of the chromogranin A-related proteins, b-granin and pancreastatin, was ob- 
tained by immune screening of rat insulinoma and pancreatic islet cDNA libraries. The sequence was virtually identical 
to that of rat adrenal chromogranin A, suggesting that the different molecular forms of chromogranin A immunoreactiv- 
ity found in adrenal medulla and endocrine pancreas are related to differences in post-translational proteolytic processing. 
The rat chromogranin A, unlike its bovine and human counterparts, contained a 20-residue glutamine sequence inserted 
within the N-terminal &granin sequence. Although the encoding CA(G/A) repeat recurs frequently in the rat genome, 
the rat chromogranin A molecule appears to be the product of a single gene and mRNA transcript. 
Chromogranin A; b-Granin; Pancreastatin; cDNA; OPA repeat; (Pancreatic islet) 
1. INTRODUCTION 
The islets of Langerhans contain a number of 
peptides which are related in structure to 
chromogranin A, a 48 kDa acidic glycoprotein 
which is the major secretory granule protein of the 
bovine adrenal chromaffin cell [l]. For example, 
pancreastatin, a peptide inhibitor of glucose- 
induced insulin and somatostatin secretion, is 
homologous to residues 251-294 of bovine 
chromogranin A [2,3]. Similarly a 21 kDa peptide, 
/3-granin, which is co-secreted with insulin from 
the pancreatic P-cell [4], resembles the N-terminus 
of the molecule [5]. 
Studies in pancreatic islets and insulinoma cells 
[6,7] indicate that /3-granin is derived from a 
chromogranin A-like precursor by excision of pairs 
of basic amino acids from the molecule. The 
primary aim of the present investigation was to 
determine the structure of the precursor and so to 
establish whether variations in the molecular sizes 
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of chromogranin A-immunoreactive peptides in 
different cells of the neuroendocrine system are 
related to differences in the precursor molecules or 
to differential proteolytic processing of a common 
precursor. 
2. MATERIALS AND METHODS 
Antibodies were raised in guinea pigs to fl-granin purified 
from a transplantable insulinoma propagated in NEDH rats (81. 
Antibodies which reacted with E. coli or h phage proteins were 
preabsorbed for 1 h at 4°C with a sonicate (25 mg protein/ml 
serum) of BNN97 E. coli grown for 16 h at 42°C with 0.5 mM 
isopropylthiogalactopyranose (IPTG). cDNA libraries were 
constructed [9] in the expression vector hgtl 1 from transplant- 
able NEDH rat insulinoma [lo] and neonatal Wistar rat islets 
isolated by collagenase digestion [ 1 I]. Nitrocellulose filter 
replicas from approx. lo5 insulinoma library clones were in- 
cubated with the preabsorbed antisera (1: 500) and then with 
horseradish peroxidase-conjugated rabbit anti-guinea pig im- 
munoglobulins (1 : 500) following a protocol for Western blot- 
ting analyses IS]. Positive clones were mapped, subcloned into 
puC18 and suitable restriction fragments sequenced in 
m13mp18/19 phage by the dideoxychain-termination pro- 
cedure. Restriction fragments from the cloned insert were 
purified by 7.5% acrylamide gel electrophoresis and used to 
screen the islet cell library after 32P radiolabelling by the ran- 
dom primer technique. 
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Southern blot analyses used Wistar rat liver nuclear DNA (40 
rg) which was digested for 16 h at 37”C, setectrophoresed in 
40 mM Tris, 1 mM EDTA, 20 mM acetate buffer on 1% 
agarose gels and blotted onto nitrocellulose. Hybridization was 
for 16 h at 42°C in 50% (v/v) formamide, 5 X SSC, 
5 x Denhardt’s, 0.1 mg/ml salmon sperm DNA, 50 mM 
phosphate (pH 6.5) containing 5x 10s dpm/ml ‘2P-labelled 
DNA and the blots subsequently washed at 65°C in 0.1 x SSC 
with 0.1% SDS [12]. 
Northern blot analyses used total RNA (2Opg) prepared from 
100-200 mg tissue by guanidine thiocyanate denaturation, CsCl 
gradient centrifugation and DNase digestion [ 121. Samples were 
glyoxylated, electrophoresed in 50 mM Na phosphate (pH 6.5) 
on 1.2% agarose gels and blotted onto nitrocellulose 1131. 
Hybridization and washing (52°C) were as above. 
Western blot analyses used guinea pig antisera (1: 500) raised 
to the P-galactosidase hybrid protein detected during the initial 
screening (clone 218/38 incorporating amino acids 60-234; 
fig.5). The protein was recovered by (NH&S04 precipitation 
(30-40% saturated pellet; pH 7.4) from lysed bacteria (Y1089 
derivative) grown at 42°C in LB media containing 1 mM IPTG. 
The precipitated protein was then chromatographed in 20 mM 
Tris-Cl (pH 7.4) containing 100 mM NaCl on a Superose 6 
HR10/30 column (Pharmacia) and the hybrid recovered as a 
145 kDa (SDS-PAGE) homogeneous product (>90% purity; 
5-10 mg/l culture). 
Purified native ,&granin [5] (30 pg) was incubated for 3 h a 
37°C in 400 ,uI of 0.5% NHdHCO3 containing 0.3 gg TPCK- 
treated trypsin (Sigma). Digests were lyophilized and 
chromatographed at 1 ml/min on a C-18 reverse-phase HPLC 
column (Waters p-bondapak) using a 9-45% (v/v) linear gra- 
dient of acetonitrile in 0.1% trifluoroacetic acid. Peak fractions 
(A ZL4 ““1 ) were subjected to automated gas-phase sequencing 
(Applied Biosystems 470A sequencer). 
3. RESULTS 
Immune screening of the rat insulinoma library 
yielded two clones having EcoRI inserts of approx. 
520 bp encoded within ,&galactosidase hybrid pro- 
teins of 130 and 145 kDa. Both clones had similar 
restriction maps and only one (218/38, fig.1) was 
examined further. The ,&galactosidase hybrid pro- 
tein encoded by this recombinant when used as an 
immunogen yielded an antibody with a reactivity 
on Western blotting which was similar in specifici- 
ty to that of the original antisera used in the screen- 
ing. It recognised proteins of 21 and 22 kDa 
C/3-granins) in insulinoma and rat islet tissue, of 21, 
22, 90 and 100 kDa in rat pituitary and a 100 kDa 
protein in rat adrenal 9 (fig.2). The clone 218/38 
was therefore considered to be authentic. 
Attempts to rescreen the insulinoma cDNA 
library for longer cDNAs using the 523 bp EcoRI 
insert from 218/38 as a probe produced a series of 
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Fig.1. Relationship of the cDNA clones obtained and the 
strategy used for sequencing. The indicated restriction sites 
were used for subcloning into m13; the direction of sequencing 
and length of readings are indicated. 
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Fig.2. Western blot analysis of different rat tissues using 
antisera raised to the cloned ,&galactosidase/fl-granin hybrid 
protein. Samples of 100 pg (islets) or 300 pg protein were 
subjected to SDS-PAGE on 7.5-1570 acrylamide gradient gels. 
The migration of protein molecular size standards is indicated 
(molecular mass expressed in kDa). 
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Fig.3. Southern blot analysis. DNA samples (40/~g/track) were 
digested overnight with the indicated enzymes, electrophoresed 
on 1°70 agarose gels, blotted and hybridized with: (A) a nick- 
translated cDNA (6 × 10 7 dpm//~g) representing bases 368-890 
of rat chromogranin A [15]; (B) an m13 probe produced by 
primer extension (2 x 10 7 dpm//~g) representing bases 368-477 
and; (C) an m13 probe (2x l0 T dpm//~g) representing bases 
478-890. The latter probe avoids the (CAGh6.(CAA)4 
sequence between bases 410 and 469. Exposure times of 
autoradiographs at -70°C: 3, 18 and 120h, respectively. 
Migration of A HindIII fragments i indicated. 
~ = .7. ~ = _7,_ ~ ,-. 
Fig.4. Northern blot analysis of insulinoma cell lines. Total 
RNA (20 izg/track) was glyoxylated and electrophoresed on 
1.2% agarose gels, blotted and hybridized to an m13 probe 
(2 × 107 dpm//~g) representing the reverse complement of bases 
478-890 of rat chromogranin A. Insulinoma line DI, although 
of the same origin as X-79 [10], is less well granulated and has 
1/5-1/10 the content of insulin and B-granin. The exposure 
time of the autoradiograph at - 70°C was 24 h. The migration 
of a 18 S ribosomal RNA is indicated. 
spurious clones related to the original sequence on- 
ly in having long tracts of a repeated CA(G/A)  se- 
quence. A 413 bp fragment of clone 218/38 
extending from a single Alu I  site to its 3 ' -end 
which omitted the CA(G/A)  repeat, however, 
yielded 3 overlapping clones from the islet library. 
These covered 1696 bp of sequence comprised of 
an open reading frame of 1360 bp and 336 bp of 
3 ' -untrans lated sequence incorporating a concen- 
sus sequence for poly(A) addition, 23 bp from the 
3 ' - terminus.  The cDNA encoded the sequence of a 
448 amino acid, 50.2 kDa precursor form of fl- 
granin and 5 amino acids of an incomplete pre- 
sequence. Six tryptic fragments of f l -granin sub- 
jected to amino acid sequencing were all 
represented in the protein, the most C-terminal of 
these extending within two residues of the probable 
proteolytic processing site at KI29R13o. An amino 
acid analysis of native ~'-granin [5] was in excellent 
agreement with the predicted composit ion of the 
14.3 kDa protein encoded by amino acids 1-128. 
The observed molecular masses ofh' -granin and its 
precursor on SDS-PAGE [6], however, are almost 
double those predicted by the sequence, a 
discrepancy probably related to anomalous elec- 
trophoretic behaviour of the molecule. 
Northern blot analysis of insul inoma tissue 
showed the presence of a single mRNA species of 
approx. 2 kb (fig.3). mRNAs of a similar size were 
found in rat adrenal and pituitary but not in rat 
liver, cerebellum and exocrine pancreas. The 
presence of the 2 kb transcript in these tissues cor- 
related with their immunoreactivity with anti-B- 
granin antisera as revealed by Western blotting. 
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Southern blot analyses performed with the nick- 
translated EcoRI insert from 218/38 showed 
hybridization to a very large number of restriction 
fragments including a number of well-defined 
bands (fig.4). The use of primer-extended ml3 
probes, however, indicated that this pattern arose 
from the same CA(G/A) repeat in the molecule 
which had been incriminated as the source of 
spurious clones obtained when initially rescreening 
the insulinoma cDNA library. Accordingly, when 
probes were used which avoided this sequence a 
single major hybridizing species was observed. 
4. DISCUSSION 
The cDNA sequence of the ,&granin precursor 
which we obtained from rat insulinoma and pan- 
creatic islet libraries corresponded to bases 
174-1871 of the recently published rat adrenal 
chromogranin A cDNA (1871 bp) [15] and was 
identical except for a deletion of a cytosine at posi- 
tion 1862. This difference lies at the extreme 
3’-end of the untranslated region and, even if real, 
is unlikely to affect the expression of the protein in 
a tissue-specific manner. Our results therefore do 
not support previous suggestions [16,17] that 
tissue-specific variants of chromogranin A mRNA 
exist. Rather, the heterogeneity of immunoreactive 
forms of chromogranin A in different tissues 
would appear to arise from proteolytic processing 
of the molecule. In the case of ,&-granin, N-linked 
glycosylation at AsnroT could also contribute to the 
observed small variations in size and charge of the 
molecule [5,8]. 
Whereas chromogranin A is a stable product of 
adrenal medullary cells [ 181, it is rapidly processed 
in pancreatic &cells [6] by proteases with proper- 
ties similar to those responsible for proinsulin con- 
version [19]. It is likely that several of the other 
dibasic sites in chromogranin A are susceptible to 
attack by the same enzymes. Of 10 such sites in the 
rat sequence, 7 are conserved in bovine [20,21] and 
human [22] chromogranins A (fig.5). Many of the 
peptides which would be produced (e.g. WE 14, 
EN 7 and AL 26) have a highly conserved sequence 
suggestive of conserved biological function. 
These results suggest hat chromogranin A is the 
actual precursor of pancreastatin. A C-terminally 
amidated peptide equivalent in size to the porcine 
molecule, however, cannot be generated simply by 
272 
excision of paired basic sequences from the rat, 
human or bovine chromogranin A sequences. The 
conservation of the Gly-Lys sequence following 
the C-terminal glycine amide of pancreastatin sug- 
gests that initial endoproteolytic attack is directed 
on the C-terminal side of the lysine, the basic 
residue is then removed by carboxypeptidase H 
and the new C-terminal glycine then acts as the 
amide donor. Enzymes which could carry out such 
conversions are present in the endocrine pancreas. 
How and where cleavage might occur on the N- 
terminal end of the pancreastatin sequence is not 
clear as the homology in this region is weak. 
Other postulated functions of chromogranin A 
include its involvement in the segregation of pro- 
teins to the regulated secretory pathway [20], 
binding of intragranular Ca’+ [21] and regulation 
of post-translational proteolysis [23]. Since the 
molecule is subject to cleavage at dibasic residues 
[7] it ought to be a competitive inhibitor of prohor- 
mone conversion, however, it is not particularly 
abundant in the pancreatic &cell (l-2% of in- 
sulin). A role in protein segregation is suggested by 
the appearance of the fibronectin cell-binding do- 
main sequence, Arg-Gly-Asp, at amino acids 
43-45 in the bovine and human chromogranin A. 
In rat chromogranin A, this site is lost 
(Arg43+Gln) though an equivalent sequence ap- 
pears at residues 403-405. It remains to be seen if 
either site is functional, especially as the membrane 
adhesion properties in fibronectin depend on addi- 
tional domains within the molecule [24]. The 
calmodulin-like Ca’+-binding domains in bovine 
chromogranin A are poorly conserved in the rat 
molecule, thus arguing against this function. 
Searches of the Doolittle, PIR, Claverie and 
Swiss protein sequence databases using the FASTP 
alignment program revealed a number of 
alignments of the polyglutamine sequence (amino 
acids 74-93) with diverse proteins such as wheat 
gliadin, the OPA repeat of Drosophila homeotic 
proteins, interleukin 2 and the rat glucocorticoid 
receptor. As in the case of the chromogranins, the 
polyglutamine tract in the rat glucorticoid receptor 
[25] is not present in the human sequence and in- 
terrupts an otherwise closely homologous region of 
the molecule. It is clear from Southern blot 
analyses and from our experience with cDNA 
library screening that the encoding CA(G/A) se- 
quence is extensively repeated in the rat genome 
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RAT 1 
BOV 1 
HUM 1 
1 2 3 4 -_ 
LPVNSPMTKGDT-CVLEVISDSLSKPSPMPVSPECLETLQGDERVLSILRHQNLLKE 60 
-------N----E----IV-----T----------K--F---R----I------------ 60 
_______N_---E----IV-----T----------Q--F---R----I------------ 60 
RAT 61 
BOV 61 
HUM 61 
RAT 121 
BOV 106 
HUM 106 
ED 210 
RAT 131 
BOV 116 
HUM 116 
5 . . . 6 
LQDLALQGAKXRAPHSSFEDELSEVFENQSPAAKHGDAASE 120 
------------T.............. .H--KK---Y-------L-KPNDQ-EPKEVTE- 105 
------------- . . . . . . . . . . . . . . . H--m--,‘-+-------L----SQ-ELKE_VE- 105 
6 
APSKDTVERR 130 HOMOLOGY 
vs---AA--- 115 64% 
PS---VM--- 115 70% 
(M,=23014) /{PANCRBAsTATIN) ..,..a, 
EDSDKGQQDAFEGTTEGPReQPEPKQESSMMGNSQSPG.....EDTANNTQSPTSLPS 185 
D-FKEVEKS..DEDSD-D----PQGLGRGPKEDN-A--...EE-EAPS-AHPLA---- 170 
---KEAEKS..GEA-D-A----L---M---K--N-A--EEEEE-EE-T--HP-A---- 173 
RAT 186 QEHGIPQTTEGSERGPSA~ARKAKQEEKEEEEEEKEEEEEEKEEKAIAREKAGP.KEV 245 
BOV 171 PKYPG--AK-D--.---.-GP-SRE-GLSA-QGRQTER------W-E-E-----V-EE-S 228 
HUM 174 -KYPG--AEGD--.-L-.-GLVDRE-GLSA-PGWQA-R-----E--E-E-G-E-V-EE-G 231 
RAT 246 
BOV 229 
HUM 232 
PIG 1 
.PTAASSSHFYSGYKKIQItDDD.GQSESQAVNGKTGASEAVPSEGKGELEHSQQEEDGEE 302 
P----FKPPPSL-N-ET-RAAPGWP.. .EDGA--M-_E__K_P_____WA__R___..__ 285 
.--VVLNP-PSL---E-R-GES~E~~~--P--E--QDP-----Q-----K-EE-- 290 
GWP-W-GA-----E--Q-P----AR-_-R---R---..-- 37 
RAT 303 
BOV 286 
HUM 291 
PIG 38 
AMAGPPQGLFPGGKGQELERKQQEEEEEEERLSREWED.KR 342 HOMOLOGY 
.--RA--V--R---SG-P........-Q--Q--K----A-- 315 40% (50%) 
.--W-----R---SG---,,.....Q---R_-K----S__ 323 47% {52%) 
ET--A-----R- 49 - (56%) 
WE 14 (&=1678) 
RAT 343 WSRMDQLAKELTAEKR 358 HOMXOGY 
BOV 316 _-K------------_ 331 93% 
HUM 324 -_K------------- 339 93% 
LL 29 (X,=3325) 
RAT 359 LEG.. ..EDDPDRSMKLSFRARAYGFRDPGPQLRR 389 HOMOLOGY 
BOV 332 -__EEEE_E_-----R------G----G--L---- 366 73% 
HUM 340 ---QEEE--m-S----------_-__G_----__ 
----N--------GLpLQV--yp---- 393 
HUM 375 -----_-___~__~~~~Q~--~~--~~ 401 
HOMOLOGY 
64% 
64% 
EN 7 &=735) 
RAT 411 EEEGSANRR 419 HOMOLOGY 
BOV 394 --------- 402 100% 
HUM 402 --------- 410 100% 
AL 26 (M,=2865) 
RAT 420 AEDQELESLSAIEAELEKVAHQLQALRRG 448 HOmLOGY 
BOV 403 P________--------------EE-_-- 432 89% 
HUM 411 p______________-_---------_-- 439 96% 
Fig.5. The deduced protein sequence of rat pancreatic chromogranin A and its homology with bovine adrenal [21] and human adrenal 
[22] chromogranin As and porcine pancreastatin [2]. The N-terminal peptide (1) and peptide sequences established from tryptic 
peptides (2-6) of ,&granin are indicated, as are the 2 consensus sequences for N-linked glycosylation (- ) and the tripeptide 
equivalent to the fibronectin receptor-binding site (+ + +). Alignments are oriented by 7 of the 10 dibasic sequences in the rat which 
are conserved and which form potential sites of endoproteolytic cleavage. The putative peptide products are designated by the N- and 
C-terminal residues followed by the peptide length. The molecular sizes of such peptides are shown in parentheses and the percentage 
homology to the rat sequence is indicated at the end of each segment. 
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and is transcribed. Since the polyglutamine se- 
quence is absent in bovine and human 
chromogranin A, one assumes it to be neutral in its 
effect, possibly separating different domains of the 
protein, rather than having a specific functional 
role in tissue-specific expression or development. 
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